Kybella

Kybella is the pick if you want a known quantity. It is a lab-made deoxycholic acid, injected under the chin to break down a pad of fat. It has a set dose, a label and a counted list of side effects. Lipodissolve is the older practice it grew out of: a mixed-to-order shot of phosphatidylcholine and deoxycholate, approved by no regulator and backed by much smaller studies.
| The difference | Kybella | Lipodissolve |
|---|---|---|
| Cost | Per vial, per session, out of pocket | Per session, and it varies by clinic |

A course of shots, recipe varies A mixture made up for the appointment. Lipodissolve is phosphatidylcholine (PC) and deoxycholate (DC), mixed by a compounding pharmacy and injected into the fat under the skin. There is no single recipe and no maker standing behind one. It is also called injection lipolysis.
Side by side
Kybella
A course of shots under the chin
A prescription injection that breaks down fat under the chin. The active ingredient is deoxycholic acid, a lab-made copy of a substance your body already uses on fat. Your provider marks a grid on the skin and injects each square. Most people need 2 to 4 sessions, a month apart.
Lipodissolve
A course of shots, recipe varies
A mixture made up for the appointment. Lipodissolve is phosphatidylcholine (PC) and deoxycholate (DC), mixed by a compounding pharmacy and injected into the fat under the skin. There is no single recipe and no maker standing behind one. It is also called injection lipolysis.
Kybella
It breaks open fat cells
It works like a detergent. Kybella breaks open the wall of the fat cell. Tissue samples show fat cells breaking down within a day. Immune cells clear the debris over the next week, and the swelling mostly settles by day 28.
Lipodissolve
The same damage, from the DC in it
The same detergent damage, from the DC. Deoxycholate is the part doing the work in both treatments. A laboratory study found the PC product and deoxycholate alone damaged cells to a similar degree. It named deoxycholate the major active part. That is why Kybella has no PC in it.
Kybella
A moderate change over several rounds
Most people improved. In two trials of 1,022 people, 68% looked better to both their doctor and themselves, versus 21% on placebo.
Big changes were less common. 16% improved by two grades, versus 1.5% on placebo. Scans showed the fat under the chin shrank by at least 10% in 43% of treated people, versus 5%.
The result seems to hold. In a follow-up study, 82% still had their improvement 3 years later. But it only included people who had already responded, and the drug's maker paid for and ran it.
Lipodissolve
Small studies, and a small effect
The studies are small, and so was the effect. The largest trial under the chin enrolled 42 people. It called the improvement minimal, with or without the PC.
Adding PC made no measurable difference. A trial in 37 women treated one side with the mixture and the other with deoxycholate alone. Fat fell on both sides, with no real difference.
Kybella
Most respond within 2 to 4 sessions
Expect a few visits, at least a month apart. The label allows up to six sessions. In the trials, most people improved a grade within 2 to 4 sessions, and 59% went through all six.
Lipodissolve
No agreed schedule
There is no agreed schedule. Published protocols differ. Some used five treatments four weeks apart, others four treatments eight weeks apart.
Kybella
Swelling, bruising, pain, numbness
Swelling and bruising are the norm. Among 513 people treated in the trials: swelling 87%, bruising 72%, pain 70%, numbness 66%.
Some of it lasts past the first month. After 30 days, 42% still had numbness and 20% still had swelling. Firmness affected 23%.
Nerve injury happened in 4%. It shows up as an uneven smile or weakness in the face. Every case in the trials cleared up on its own, after 44 days on average.
Plan for some time off. In one study, 13% of people missed work after the first session, about a day.
Lipodissolve
Swelling, redness, pain, firmness
The studies report swelling, redness, pain and firmness. There is no side-effect table, because there is no standard recipe.
The reported list is longer. Plastic surgeons also list bruising, itching, pigment change and numbness, plus rarer problems such as abscesses, ulcers, nerve injury and infection.
Kybella
Per vial, per session, out of pocket
You pay per vial, per session, out of your own pocket. Budget for a course of 2 to 4 sessions rather than one visit.
Lipodissolve
Per session, and it varies by clinic
There is no standard product, so there is no standard price. It depends on the mixture the clinic makes up and how many sessions it plans.
Kybella
Lipodissolve
Lipodissolve
Lipodissolve has never been approved for anything. In 2010 the FDA sent seven warning letters over its marketing. Sellers had no support for claims of an outstanding safety record, or of better results than liposuction.
Kybella
Kybella is synthetic deoxycholic acid at 10 mg/mL in a 2 mL single-patient vial. It was developed as ATX-101 by Kythera Biopharmaceuticals, later acquired by Allergan, and is now distributed by AbbVie. The FDA approved it on 29 April 2015 under NDA 206333. Label last revised October 2024.
The approved use is "improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults." Use outside the submental region "has not been established and is not recommended." A session allows up to 50 injections of 0.2 mL, 1 cm apart, to a maximum of 10 mL. Sessions run at least a month apart, up to six.
Lipodissolve
There is no FDA-approved lipodissolve product for any body area, and no standard formulation. The FDA's consumer page, content current as of December 2023, names it among unapproved fat-dissolving injections.
Common questions
The FDA also listed harms it had heard about. Those were permanent scarring, skin deformation, and deep painful knots under the skin. It still lists lipodissolve as unapproved.